Assessment of acute pancreatitis severity via determination of serum levels of hsa‑miR‑126‑5p and IL‑6
Authors:
Open Access
- 9 November 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (1) , 1
Abstract
Early assessment of acute pancreatitis (AP) severity is key to its treatment. The present study aimed to explore the role of microRNAs (miRNAs/miRs) combined with inflammatory factors in determining AP severity. For this, serum pro‑inflammatory cytokines [tumor necrosis factor (TNF)‑α, interleukin (IL)‑1, IL‑6, IL‑8 and IL‑10)] and miRNAs [Homo sapiens (hsa)‑miR‑548d‑5p, hsa‑miR‑126‑5p and hsa‑miR‑130b‑5p] were detected in patients with mild AP (MAP), severe AP (SAP) and recurrent AP (RAP). High expression of IL‑10, TNF‑α, hsa‑miR‑126‑5p, hsa‑miR‑548d‑5p and hsa‑miR‑130b‑5p was able to distinguish SAP from MAP and RAP (P<0.05). Multifactorial binary logistic regression analysis indicated that IL‑1/IL‑6 combined with hsa‑miR‑126‑5p/hsa‑miR‑548d‑5p had a significant influence on AP and AP severity (P<0.05). Receiver operating characteristic analysis revealed that IL‑1 combined with hsa‑miR‑126‑5p [area under the curve (AUC), 0.926; sensitivity, 90.0%; specificity, 86.7%, P<0.001] and IL‑6 combined with hsa‑miR‑126‑5p (AUC, 0.952; sensitivity, 93.3%; specificity, 90.0%; P<0.001) were able to better distinguish MAP from SAP than IL‑1/IL‑6 combined with hsa‑miR‑548d‑5p, lipase, and amylase. IL‑1 or IL‑6 combined with hsa‑miR‑548d‑5p (AUC, 0.924; sensitivity, 83.3%; specificity, 93.3%; P<0.001) were able to better distinguish SAP from RAP than IL‑1/IL‑6 combined with hsa‑miR‑126‑5p, lipase, and amylase. IL‑1 combined with hsa‑miR‑126‑5p (AUC, 0.926; sensitivity, 90.0%; specificity, 86.7%; P<0.001) and IL‑6 combined with hsa‑miR‑126‑5p (AUC, 0.952; sensitivity, 93.3%; specificity, 90.0%; P<0.001) were able to better differentiate between MAP and RAP than IL‑1/IL‑6 combined with hsa‑miR‑548d‑5p, lipase, and amylase. These results demonstrated that the combined detection of serum IL‑6 and hsa‑miR‑126‑5p may be useful for the early prediction of AP classification.Keywords
This publication has 38 references indexed in Scilit:
- MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3PLOS ONE, 2013
- Interleukin‐6: Possible biological roles during exerciseEuropean Journal of Sport Science, 2013
- Assessing sample and miRNA profile quality in serum and plasma or other biofluidsMethods, 2013
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancerOncology Letters, 2012
- The ST2 Pathway Is Involved in Acute PancreatitisThe American Journal of Pathology, 2012
- MicroRNA miR-548d Is a Superior Regulator in Pancreatic CancerPancreas, 2012
- Different profiles of cytokine expression during mild and severe acute pancreatitisWorld Journal of Gastroenterology, 2010
- Inflammatory mediators in acute pancreatitisBritish Journal of Surgery, 1995
- Inflammatory mediators in acute pancreatitisBritish Journal of Surgery, 1995